Thursday, August 16, 2018
 
 
Company News: Page (1) of 1 - 08/09/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Regulations for Monitoring Medical Assistance in Dying Come into Force
 
(August 09, 2018)

The regulations will come into force November 1, 2018

OTTAWA, Aug. 9, 2018 /CNW/ - The Government of Canada recognizes that medical assistance in dying is a deeply personal issue for all Canadians and must be addressed with the utmost compassion and empathy. It is critically important to monitor how the legislation is being implemented across the country to understand how the wishes of eligible patients are being carried out, and to protect the most vulnerable. Public reporting in this area is key to ensuring transparency and fostering public trust.

Today, the Government of Canada published final regulations in Canada Gazette, Part II that create a federal pan-Canadian monitoring system on medical assistance in dying. The regulations set out reporting requirements for physicians and nurse practitioners who receive written requests for medical assistance in dying, and for pharmacists who dispense medication for assisted dying. Any personal data collected will be protected under the federal Privacy Act.



The information will be used to publish annual reports on medical assistance in dying in Canada, including the number of requests received, the number of medically assisted deaths and the number of people found ineligible. The regulations come into force on November 1, 2018, and providers have until that date to become familiar with the new reporting requirements.

Health Canada expects to continue to produce interim reports until the permanent monitoring and reporting system is operational. Annual federal reporting using the data collected under the Regulations is expected to begin in 2019.

Quotes

"Medical assistance in dying is a sensitive, complex issue and many Canadians have deeply-held views on the subject. We are committed to ensuring that Canadians who choose medical assistance in dying have access to these services. These regulations promote transparency and will help us monitor how this service is being implemented across the country."

The Honourable Ginette Petitpas Taylor
Minister of Health

Quick Facts:

  • On June 17, 2016, Parliament passed legislation that allows eligible Canadian adults to request medical assistance in dying. This legislation is now part of the Criminal Code and exempts physicians and nurse practitioners from certain criminal offences if they provide or assist in providing medical assistance in dying according to the eligibility requirements and safeguards in the law.
  • There have been 3,714 medically assisted deaths in Canada since the legislation was enacted.
  • Medically assisted deaths account for approximately 1.07% of all deaths nationally according to the latest data. Overall, the numbers are consistent with international experience.
  • The majority of Canadians who received assistance in dying were between 56 and 90 years old. The average age was approximately 73 years old.

Related Products

 

SOURCE Health Canada

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Adults,Medical Professionals,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • Wearable Medical Devices Global Market Opportunities And Strategies To 2022
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  • ViewRay Announces Pricing of Public Offering of Common Stock
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines